Cost-Utility of a Prognostic Test Guiding Adjuvant Chemotherapy Decisions in Early-Stage Non-Small Cell Lung Cancer

D. Stenehjem, David; K. Bellows, Brandon; M. Yager, Kraig; T. Jones, Joshua; Kaldate, Rajesh; Siebert, Uwe; Brixner, Diana

doi:10.1634/theoncologist.2015-0162

Public

Cost-Utility of a Prognostic Test Guiding Adjuvant Chemotherapy Decisions in Early-Stage Non-Small Cell Lung Cancer

Published in The Oncologist • Nov 27, 2015

Authors:

David D. Stenehjem

Brandon K. Bellows

Kraig M. Yager

Abstract

BACKGROUND: A prognostic test was developed to guide adjuvant chemotherapy (ACT) decisions in early-stage non-small cell lung cancer (NSCLC) adenocarcinomas. The objective of this study was to compare the cost-utility of the prognostic test to the current standard of care (SoC) in patients with earl...

Subject

Medicine

Lung cancer

Stage (stratigraphy)

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!